On May 29, 2012, the Center for Regulatory Effectiveness filed comments supporting an industry petition critical of EPA’s Endocrine Disruptor Screening Program.  Among other comments, CRE requested that EPA have a FIFRA Science Advisory Panel review several aspects of the EDSP before EPA takes any further action on this program.

● Click below to read CRE’s comments supporting EDSP petition.